Research Article
Tumor Mutation Load: A Novel Independent Prognostic Factor in Stage IIIA-N2 Non-Small-Cell Lung Cancer
Figure 4
The somatic mutation targets in recurrence and recurrence-free stage IIIA-N2 NSCLC patients: (a) mutation ; (b) mutation .
(a) |
(b) |